ZytoLight ® SPEC ERG/TMPRSS2 TriCheckTM Probe

The ZytoLight ® SPEC ERG/TMPRSS2 TriCheckTM Probe is designed to detect deletions between the ERG and the TMPRSS2 gene at 21q22 resulting in the TMPRSS2-ERG fusion frequently observed in prostate cancer. Furthermore, the triple color approach allows the detection of other translocations affecting either of these genes.

Probe Maps


Ordering Information

Prod. No.:Tests¹ (Volume):Registration Status²:
20 (200 µl)

Download Information


1 Using 10 μl probe solution per test.
2 In vitro diagnostic medical device according to EU directive 98/79/EC. 
CE IVD only available in certain countries. All other countries research use only! 
Please contact your local dealer for more information.

ISO 9001
ISO 13485
ZytoVision GmbH


For ZytoVision products additional information is available, which is only valid outside the United States of America (USA). With this action you confirm that you have read this legal notice, that you agree with the terms of use, and that you are not intending to use the information provided on this website within USA.

Accept & Continue